Table 2 End of therapy outcomes

Length of stay, days^{a, b}

9 [5–17]

Clinical cure, n (%)

80 (85.1)

Mortality, n (%)

5 (5.3)

B. melitensis antibody titer^{a, c}

1:320 1:320–1:640

B. melitensis antibody titer < 1:320, n (%)^c

28 (29.8)

B. abortus antibody titer^{a, c}

1:320 1:160–1:640

B. abortus antibody titer < 1:320, n (%)^c

33 (35.1)

Temperature, °C^a

36.7 [36.5–36.9]

white blood cells count, cells/mm³

6.2 ± 3.4

C-reactive protein, mg/L^a

3.2 [3.1–3.3]

erythrocyte sedimentation rate, mm/hr^a

8 [5–22]